NCT07065968 The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2) Status RECRUITING Phase PHASE2
NCT07064889 The Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia Status NOT_YET_RECRUITING Phase PHASE2
NCT07056244 Dexmedetomidine Versus Dexamethasone as Adjuvants to Bupivacaine in Caudal Epidural Block Status RECRUITING Phase NA
NCT07052864 IV Dexamethasone in Preventing Post Spinal Hypotension Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT07032714 Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma Status RECRUITING Phase PHASE1
NCT07019545 A PHASE II TRIAL AIMING TO INVESTIGATE THE SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA PREVIOUSLY TREATED WITH A THROMBOPOIETIN RECEPTOR AGONIST AND/OR RITUXIMAB AFTER CORTICOSTEROID FIRST-LINE THERAPY Status NOT_YET_RECRUITING Phase PHASE2
NCT07018050 Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma Status RECRUITING Phase PHASE2
NCT07015021 The Efficacy and Safety of the Combination Therapy of Daratumumab, Cabozantinib, Pomalidomide, and Dexamethasone (D-KPd) in the Treatment of High-risk First-time Relapsed or Primary Refractory MM Patients Status NOT_YET_RECRUITING Phase NA
NCT06997081 ERd Combination Treatment in Newly Diagnosed Multiple Myeloma Status RECRUITING Phase PHASE2
NCT06988488 A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma Status RECRUITING Phase PHASE1/PHASE2
NCT06981754 Dexamethasone Palmitate for PONV After Minimally Invasive Endoscopic Surgery Status RECRUITING Phase NA
NCT06980727 Comparative Efficacy of IV Dexamethasone vs. Nebulized Terbutaline for Renal Colic Pain in the ED Status NOT_YET_RECRUITING Phase PHASE3
NCT06968559 Effect of Early Dexamethasone on Major Complications and All-cause Mortality in Severe Burns Status RECRUITING Phase PHASE3
NCT06968507 Comparison of the Effectiveness of Oral and Intratympanic Corticosteroid Treatments in Patients Diagnosed With Sudden Sensorineural Hearing Loss Status RECRUITING Phase PHASE4
NCT06956170 All Japanese Population: Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06953960 A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM) Status RECRUITING Phase PHASE1/PHASE2
NCT06948084 Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse Status NOT_YET_RECRUITING Phase PHASE2